This site is intended for healthcare professionals only
LoginRegister
Novartis concludes acquisition of Tourmaline BioNovartis Healthcare gets CDSCO Panel nod to study Iptacopan
CDSCO Panel Seeks Revised Phase IV Study for Zydus Empagliflozin, Metformin FDCConduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on Glycopyrrolatem plus Indacaterol...
Abbott Volt Pulsed Field Ablation System bags USFDA approval for atrial fibrillationAbbott's Plea Alleging NPPA Used Outdated PTR Data for Metoprolol Pricing Rejected by DoP
Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in IndiaEli Lilly Collaborates with Laekna to Develop Obesity Drug Targeting Muscle Preservation and Weight...
Novartis Loses India Patent on Heart Failure Drug VymadaDespite Pluvicto, MorphoSys Setbacks, Novartis Raises 2028 Sales Growth Outlook to 6%
Like USFDA, we need Bharat Food and Drug Administration for global benchmarks, says FM SitharamanLike USFDA, we need Bharat Food and Drug Administration for global benchmarks, says FM Sitharaman
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionMSN Laboratories Gets CDSCO Panel nod to Manufacture, Market Tolvaptan Tablets 7.5 mg
Lupin and TB Alliance Join Forces to Advance TelacebecRevise protocol for Denosumab 60 mg prefilled syringe solution for injection: CDSCO Panel tells...
Madras HC Upholds Centres One-Year Contract Extension of DCGIDCGI Warns Cosmetic Industry Against Overlapping Claims With Pharma Products
Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide allianceDr Reddy's, Aurobindo Pharma, 4 Others Ink MoUs for Rs 5,260 Crore Pharma City Investment
Ayurveda doctor fined Rs 50,000 for advertising product, making cure claims through social media adsPunjab: Tribunal Slaps Rs 5 Crore Interim Fine on Pharma Unit for Violations
Torrent Pharma Appoints Former Cipla Global CTO Geena Malhotra as Chief Technology OfficerTorrent Pharma Receives USFDA Clearance for Pithampur Facility with VAI Classification
X